-
Subject Areas on Research
-
A glomerular transcriptomic landscape of apolipoprotein L1 in Black patients with focal segmental glomerulosclerosis.
-
A pharmacogenetic investigation of intravenous furosemide in decompensated heart failure: a meta-analysis of three clinical trials.
-
APOL1 Genotype and Kidney Transplantation Outcomes From Deceased African American Donors.
-
APOL1 Kidney Risk Variants and Cardiovascular Disease: An Individual Participant Data Meta-Analysis.
-
APOL1 Nephrotoxicity: What Does Ion Transport Have to Do With It?
-
APOL1 Risk Variants, Acute Kidney Injury, and Death in Participants With African Ancestry Hospitalized With COVID-19 From the Million Veteran Program.
-
APOL1 genotype-associated morphologic changes among patients with focal segmental glomerulosclerosis.
-
APOL1 kidney disease risk variants cause cytotoxicity by depleting cellular potassium and inducing stress-activated protein kinases.
-
APOL1 risk alleles among individuals with CKD in Northern Tanzania: A pilot study.
-
APOL1 variants in HIV-associated nephropathy: just one piece of the puzzle.
-
APOL1 variants increase risk for FSGS and HIVAN but not IgA nephropathy.
-
APOL1-G0 or APOL1-G2 Transgenic Models Develop Preeclampsia but Not Kidney Disease.
-
APOL1-G0 protects podocytes in a mouse model of HIV-associated nephropathy.
-
APOL1-associated kidney disease in northern Nigerians with treated HIV infection.
-
APOL1: a case in point for replacing race with genetics.
-
Apolipoprotein L1 (APOL1) Coding Variants Are Associated With Creatinine Rise After Cardiac Surgery.
-
Apolipoprotein L1 gene variants in deceased organ donors are associated with renal allograft failure.
-
Apolipoprotein-1 risk variants and associated kidney phenotypes in an adult HIV cohort in Nigeria.
-
Comparing Kidney Health Outcomes in Children, Adolescents, and Adults With Focal Segmental Glomerulosclerosis.
-
Deceased donor multidrug resistance protein 1 and caveolin 1 gene variants may influence allograft survival in kidney transplantation.
-
Deceased-Donor Apolipoprotein L1 Renal-Risk Variants Have Minimal Effects on Liver Transplant Outcomes.
-
Design and rationale of GUARDD-US: A pragmatic, randomized trial of genetic testing for APOL1 and pharmacogenomic predictors of antihypertensive efficacy in patients with hypertension.
-
Effect of Genetic African Ancestry on eGFR and Kidney Disease.
-
Emerging Viral Infections and the Potential Impact on Hypertension, Cardiovascular Disease, and Kidney Disease.
-
Establishing the value of genomics in medicine: the IGNITE Pragmatic Trials Network.
-
Etiology of Persistent Microalbuminuria in Nigeria (P_MICRO study): protocol and study design.
-
Evolutionary genetics and acclimatization in nephrology.
-
Examination of Potential Modifiers of the Association of APOL1 Alleles with CKD Progression.
-
Genetic Basis of Health Disparity in Childhood Nephrotic Syndrome.
-
Genetic Modifiers of Sickle Cell Disease.
-
HIV at 40: kidney disease in HIV treatment, prevention, and cure.
-
HLA-DQA1 and APOL1 as Risk Loci for Childhood-Onset Steroid-Sensitive and Steroid-Resistant Nephrotic Syndrome.
-
Host APOL1 genotype is independently associated with proteinuria in HIV infection.
-
In vivo Modeling Implicates APOL1 in Nephropathy: Evidence for Dominant Negative Effects and Epistasis under Anemic Stress.
-
Integrative Genomics Identifies Novel Associations with APOL1 Risk Genotypes in Black NEPTUNE Subjects.
-
JAK inhibitor blocks COVID-19 cytokine-induced JAK/STAT/APOL1 signaling in glomerular cells and podocytopathy in human kidney organoids.
-
Kidney Disease-Associated APOL1 Variants Have Dose-Dependent, Dominant Toxic Gain-of-Function.
-
MYH9 and APOL1 are both associated with sickle cell disease nephropathy.
-
Obesity and synergistic risk factors for chronic kidney disease in African American adults: the Jackson Heart Study.
-
Pathophysiology and Pathology of Acute Kidney Injury in Patients With COVID-19.
-
Podocyte density is reduced in kidney allografts with high-risk APOL1 genotypes at transplantation.
-
RNA sequencing of isolated cell populations expressing human APOL1 G2 risk variant reveals molecular correlates of sickle cell nephropathy in zebrafish podocytes.